KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Interest Expenses (2023 - 2026)

Fulgent Genetics' Interest Expenses history spans 4 years, with the latest figure at $17000.0 for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 21.43% to $17000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $78000.0, a 16.13% decrease, with the full-year FY2025 number at $75000.0, up 144.12% from a year prior.
  • Interest Expenses hit $17000.0 in Q1 2026 for Fulgent Genetics, up from $16000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for FLGT hit a ceiling of $70000.0 in Q3 2023 and a floor of -$249000.0 in Q1 2024.
  • Historically, Interest Expenses has averaged -$13181.8 across 4 years, with a median of $17000.0 in 2025.
  • The widest YoY moves for Interest Expenses: up 129.2% in 2024, down 80.0% in 2024.
  • Tracing FLGT's Interest Expenses over 4 years: stood at -$137000.0 in 2023, then skyrocketed by 129.2% to $40000.0 in 2024, then plummeted by 60.0% to $16000.0 in 2025, then grew by 6.25% to $17000.0 in 2026.
  • Business Quant data shows Interest Expenses for FLGT at $17000.0 in Q1 2026, $16000.0 in Q4 2025, and $28000.0 in Q3 2025.